Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

287 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Antithrombotic effects of abciximab.
Hayes R, Chesebro JH, Fuster V, Dangas G, Fallon JT, Sharma SK, Coller BS, Badimon L, Marmur JD, Badimon JJ. Hayes R, et al. Among authors: coller bs. Am J Cardiol. 2000 May 15;85(10):1167-72. doi: 10.1016/s0002-9149(00)00722-0. Am J Cardiol. 2000. PMID: 10801995 Clinical Trial.
Monoclonal antibody against the platelet glycoprotein (GP) IIb/IIIa receptor prevents coronary artery reocclusion after reperfusion with recombinant tissue-type plasminogen activator in dogs.
Yasuda T, Gold HK, Fallon JT, Leinbach RC, Guerrero JL, Scudder LE, Kanke M, Shealy D, Ross MJ, Collen D, Coller BS. Yasuda T, et al. Among authors: coller bs. J Clin Invest. 1988 Apr;81(4):1284-91. doi: 10.1172/JCI113446. J Clin Invest. 1988. PMID: 2832448 Free PMC article.
Differential inhibition of platelet aggregation induced by adenosine diphosphate or a thrombin receptor-activating peptide in patients treated with bolus chimeric 7E3 Fab: implications for inhibition of the internal pool of GPIIb/IIIa receptors.
Kleiman NS, Raizner AE, Jordan R, Wang AL, Norton D, Mace KF, Joshi A, Coller BS, Weisman HF. Kleiman NS, et al. Among authors: coller bs. J Am Coll Cardiol. 1995 Dec;26(7):1665-71. doi: 10.1016/0735-1097(95)00391-6. J Am Coll Cardiol. 1995. PMID: 7594101 Free article.
Administration of abciximab during percutaneous coronary intervention reduces both ex vivo platelet thrombus formation and fibrin deposition: implications for a potential anticoagulant effect of abciximab.
Dangas G, Badimon JJ, Coller BS, Fallon JT, Sharma SK, Hayes RM, Meraj P, Ambrose JA, Marmur JD. Dangas G, et al. Among authors: coller bs. Arterioscler Thromb Vasc Biol. 1998 Aug;18(8):1342-9. doi: 10.1161/01.atv.18.8.1342. Arterioscler Thromb Vasc Biol. 1998. PMID: 9714143 Clinical Trial.
287 results